GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK has announced that the US FDA approved Blujepa (gepotidacin), a new ...

Dame Emma Walmsley, Chief Executive one of Britain's biggest pharmaceutical companies GSK (GlaxoSmithKline), says the company is prioritising the United States for product launches and investment, ...

GlaxoSmithKline ( ($GB:GSK) ) has shared an update. GlaxoSmithKline (GSK) has announced a transaction involving the purchase of 217,000 of its own ...

GlaxoSmithKline Pharmaceuticals Limited ( (IN:GLAXO) ) has shared an update.

This morning, GlaxoSmithKline announced a $3 billion criminal settlement with the Department of Justice to settle accusations that it didn't tell regulators about safety problems with an infamous drug ...

TRENTON, N.J. (AP) -- British drugmaker GlaxoSmithKline will pay $3 billion in fines — the largest health care fraud settlement in U.S. history — for criminal and civil violations involving 10 drugs ...

A partnership between a large British drugmaker and a startup that discovers drugs using artificial intelligence has borne fruit. Oxford, UK-based Exscientia said Wednesday that it had delivered the ...

CARLISLE - GlaxoSmithKline, one of the world’s largest pharmaceutical companies, confirmed Monday that it will close a manufacturing facility in Carlisle next year. Production in Carlisle will end by ...

According to news reports, in April 2021, activist investment firm Elliott Management Corp. acquired a large stake in GSK to put pressure on Chief Executive Officer (CEO), Emma Walmsley, to accelerate ...

Five former GSK employees deported from China. BEIJING— -- China has fined the British pharmaceuticals giant GlaxoSmithKline (GSK) $488.8 million (3 billion Yuan) for a "massive bribery network" ...

One of these big pharma stocks appears to have an advantage. The reason behind these declines is that both GlaxoSmithKline and Pfizer have a lot more going on than just their COVID-19 programs. Which ...

Consumer genetic testing company 23andMe announced on Wednesday that GlaxoSmithKline purchased a $300 million stake in the company, allowing the pharmaceutical giant to use 23andMe’s trove of genetic ...